Real-World HIV drug study tracks Doravirine's effectiveness

NCT ID NCT05421806

First seen Jan 07, 2026 · Last updated Apr 30, 2026 · Updated 17 times

Summary

This study follows 500 people with HIV across Europe who are taking the medication doravirine. Researchers want to see how well the drug controls the virus over 12 months, how many people stop taking it, and if the virus becomes resistant. The study includes people new to treatment, those switching from other drugs, and those with specific viral mutations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV I INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Bichat-Claude Bernard Hospital

    Paris, France

  • CHU Nantes University Hospital

    Nantes, France

  • CHU de Nantes

    Nantes, France

  • Chelsea and Westminster Hospital

    London, United Kingdom

  • Erasmus University Medical Center

    Rotterdam, Netherlands

  • Guy's Hospital

    London, United Kingdom

  • Hopital Universitaire Pitie-Salpetriere

    Paris, France

  • Hospital Center University De Montpellier

    Montpellier, France

  • Hospital Center University De Nice

    Nice, France

  • Hospital Clínic de Barcelona

    Barcelona, Spain

  • Hospital Saint Antoine

    Paris, France

  • Institute Of Tropical Medicine Antwerp

    Antwerp, Belgium

  • Lariboisière Hospital

    Paris, France

  • Mortimer Market Center, Central and North West London NHS Trust

    London, United Kingdom

  • Saint-Louis Hospital

    Paris, France

  • Saint-Pierre University Hospital

    Brussels, Belgium

  • Southmead Hospital

    Bristol, United Kingdom

  • St Louis Hospital

    Paris, France

  • University Hospitals Pitié Salpêtrière

    Paris, France

Conditions

Explore the condition pages connected to this study.